Valued at USD 2.5 billion in 2024, the apheresis equipment market is projected to reach USD 2.68 billion in 2025 and USD 5 billion by 2034, growing at a CAGR of 7.00% during the forecast period 2025–2034. Medical technology advances, a rising chronic disease burden and growing demand for blood components are lifting procedure volumes, while innovation in procedures and separation technologies is reshaping competition across the apheresis equipment market.

Procedure Segmentation in the Apheresis Equipment Market

The report segments the market by procedure into plasmapheresis, photopheresis, leukapheresis, plateletpheresis, LDL apheresis, erythrocytapheresis and others. Plasmapheresis and photopheresis address distinct clinical needs, from removing plasma components to treating selected conditions, while plateletpheresis and LDL apheresis serve donor and specialized therapeutic requirements. This breadth allows manufacturers to position platforms across multiple care pathways, including renal diseases, hematology, neurology and other applications. Applications are segmented into renal diseases, hematology, neurology and others, with hematology holding the dominant revenue share in 2024.

Membrane Filtration and Centrifugation Technologies

By technology, the market is divided into membrane filtration and centrifugation. Both approaches separate the desired blood element while returning remaining components to the patient. Polaris observes a trend toward more sophisticated equipment that offers enhanced precision, user-friendliness and reduced procedure times. Whether a system relies on membrane filtration or centrifugation, buyers increasingly prioritize efficiency and safety, and vendors compete on automation, usability and consumable compatibility. The report also segments the market by product into disposable kits and devices, with kits dominating the product category in 2024.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market

Portable Apheresis Devices and AI Integration

Technological innovation, including automated and portable apheresis devices, is enhancing efficiency and safety and boosting market adoption. The integration of artificial intelligence and data analytics is improving the monitoring and management of procedures, supporting better patient outcomes. There is also a growing trend toward cost-effective solutions that make apheresis more accessible, particularly in low and middle-income countries. For suppliers, portable apheresis devices and connected analytics represent a pathway to broaden the installed base. Expansion of healthcare infrastructure in emerging economies is expected to widen access further. Technological innovation, including automated devices, enhances efficiency and safety and further boosts adoption.

Cost and Training Barriers

The high cost of equipment and procedures remains a significant restraint. Advanced machines require substantial investment to purchase and maintain, and the expense of consumables, skilled labor and ongoing maintenance weighs heavily on smaller hospitals and clinics. The financial barrier is more pronounced in low- and middle-income countries. In addition, the complexity of apheresis procedures necessitates specialized training, which limits adoption in less developed healthcare systems and slows overall market growth. Manufacturers addressing these barriers with cost-effective designs may find opportunity in resource-limited settings.

Competitive Landscape

The competitive landscape is characterized by several key players actively pursuing innovation and strategic initiatives. Participants include Asahi Kasei Corporation, B. Braun SE, Cerus Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Medica SPA, Miltenyi Biotec, NIKKISO Medical Europe GmbH, NxStage Medical, Inc., SB-KAWASUMI LABORATORIES, INC., TERUMO BCT, INC. and THERAKOS. Market leaders leverage extensive portfolios, advanced technologies and robust distribution networks, and rely on collaborations, mergers and acquisitions and partnerships to expand reach. North America remains the largest market, while Asia Pacific is expected to grow substantially, giving vendors a two-region strategic focus.

Recent Developments

In September 2025, the European Commission granted marketing authorization for Grifols' Spectra Optia Apheresis Equipment  System, described as the first fully automated, disposable apheresis system approved in Europe, designed to improve operational efficiency and reduce costs for healthcare providers. In March 2024, Fresenius Medical Care partnered with GE Healthcare to co-develop and commercialize integrated apheresis and dialysis systems, aiming to improve care coordination for patients undergoing apheresis and hemodialysis. These moves illustrate how partnerships and acquisitions are reshaping the competitive picture. Strategic collaborations expand market reach and technological capabilities.

More Trending Latest Reports By Polaris Market Research:

tokenization-market

in-depth-overview-of-the-leading-7-companies-in-the-anime-market

epdm-market

service-robotics-market

leading-top-20-companies-in-the-wheat-protein-market-in-2025

cell-and-gene-therapy-contract-research-organizations-market

term-insurance-market

property-management-market

air-traffic-management-market